This past Monday, Jared Bauer took the stage on behalf of Seek Labs as an invited company presenter at the BIO CEO & Investor Conference in New York City. Bauer spoke about Seek Labs’ recent developments in molecular diagnostic innovation.
Addressing a diverse assembly of industry leader and investors, Bauer’s presentation underscored Seek Labs’ commitment to driving forward point-of-care molecular diagnostics and innovations to improve global health. Bauer outlined strategic pathways for navigating dynamic diagnostics market and leveraging opportunities for Seek Labs’ continued success.
The BIO CEO & Investor Conference gathers global industry-leading executives and investors from across the life sciences industry. The BIO CEO & Investor Conference serves as a platform for Seek Labs to share the groundbreaking progress in diagnostic innovation with industry thought leaders and investors. Bauer’s participation as a speaker underscores Seek Labs’ pivotal role in shaping the point-of-care molecular diagnostics industry in shaping the future of innovation technologies.
About Seek Labs
Seek Labs is a company united by a vision to advance scientific discovery and universal solutions. Seek Labs strives to innovate healthcare solutions that bridge gaps between patients, providers, and treatments. Seek Labs is united by the passion of our founders and their shared beliefs that healthcare solutions should empower individuals and serve their specific needs. Today—after years of experimentation, failure, and breakthrough— Seek Labs is developing new solutions for point-of-care diagnostics and CRISPR-based pharmaceutical technologies that have the potential to revolutionize the detection and treatment of diseases.
Seek Labs is headquartered in Salt Lake City, Utah. Seek Labs is a proud member of the BioHive, a collective representing the life science and healthcare innovation ecosystem in Utah. BioHive is dedicated to all the ways our work can positively impact the lives of our community, our teams, and patients.